The medication Xalkori® (crizotinib) is used to treat advanced non-small cell lung cancer in adults age 18 and older. It is approved for use in people who have a specific gene called the abnormal anaplastic lymphoma kinase (ALK) gene. This abnormal gene is responsible for causing cancer growth.
Xalkori comes in capsule form and is usually taken twice daily. Because this medication is not appropriate for everyone, your healthcare provider will need certain information from you before prescribing it. Some of this information includes a complete list of all medical conditions you have (including allergies) and all other medications, vitamins, and supplements you are currently taking.
Possible side effects of this medication include vision problems, vomiting, and diarrhea. However, most people tolerate it well -- if adverse reactions do occur, they are typically mild and easily treated.
(Click Xalkori for more information on this medication, including when and how to take it, other side effects to be aware of, and dosing information.)
Written by/reviewed by: Arthur Schoenstadt, MD
Last reviewed by: ArthurSchoenstadt, MD
List of references (click here):
Xalkori [package insert]. New York, NY: Pfizer Labs;2011 August.
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed October 20, 2011.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click